Clinical Trial Update: Customized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is assessing customized antibiotic treatment duration for hospitalized patients with moderately severe community-acquired pneumonia; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Community-Acquired Pneumonia | Phase 3 | Status: RECRUITING